Endotronix Announces First in Human Implantation

Cornerstone portfolio company, Endotronix, a medical technology company providing device and digital health solutions for heart failure management, announced on January 24th, 2018, a successful first-in-human implantation of the Cordella Pulmonary Artery (PA) Pressure Sensor and initiation of the SIRONA First-in-Human (FIH) clinical trial.

The wireless Cordella PA Pressure Sensor, the implantable component of the CordellaHeart Failure (HF) System, provides PA pressure data readings that clinicians interpret to guide therapy and provide proactive HF management.


This entry was posted in Blog and tagged , , , , . Bookmark the permalink.